URL: http://useast.ensembl.org/index.html

Publications: Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, Austine-Orimoloye O, Azov AG, Barnes I, Bennett R, Berry A, Bhai J, Bignell A, Billis K, Boddu S, Brooks L, Charkhchi M, Cummins C, Da Rin Fioretto L, Davidson C, Dodiya K, Donaldson S, El Houdaigui B, El Naboulsi T, Fatima R, Giron CG, Genez T, Martinez JG, Guijarro-Clarke C, Gymer A, Hardy M, Hollis Z, Hourlier T, Hunt T, Juettemann T, Kaikala V, Kay M, Lavidas I, Le T, Lemos D, Marugán JC, Mohanan S, Mushtaq A, Naven M, Ogeh DN, Parker A, Parton A, Perry M, Piližota I, Prosovetskaia I, Sakthivel MP, Salam AIA, Schmitt BM, Schuilenburg H, Sheppard D, Pérez-Silva JG, Stark W, Steed E, Sutinen K, Sukumaran R, Sumathipala D, Suner MM, Szpak M, Thormann A, Tricomi FF, Urbina-Gómez D, Veidenberg A, Walsh TA, Walts B, Willhoft N, Winterbottom A, Wass E, Chakiachvili M, Flint B, Frankish A, Giorgetti S, Haggerty L, Hunt SE, IIsley GR, Loveland JE, Martin FJ, Moore B, Mudge JM, Muffato M, Perry E, Ruffier M, Tate J, Thybert D, Trevanion SJ, Dyer S, Harrison PW, Howe KL, Yates AD, Zerbino DR, Flicek P. Ensembl 2022. Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995. doi: 10.1093/nar/gkab1049. PMID: 34791404.

Funding/Acknowledgements: Wellcome Trust [WT108749/Z/15/Z]; National Human Genome Research Institute of the National Institutes of Health [U41HG007823, 2U41HG007234, U41HG010972, 2U24HG007497-05]; Biotechnology and Biological Sciences Research Council [BB/N019563/1, BB/M011615/1, BB/S020152/1, BB/P016855/1, BB/S02011X/1, BB/P024602/1]; Open Targets, Wellcome Trust [WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z, WT108749/Z/15/A, WT212925/Z/18/Z, WT218328/B/19/Z]; British Council [414710385]; ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory; European Union's Horizon 2020 research and innovation programme [733161 (MultipleMS), 731060 (INFRAVEC2), 825575 (EJP RD), 817923 (AQUA-FAANG), 817998 (GENESWitCH), 815668 (BovReg)]; Save the Tasmanian Devil Program. Funding for open access charge: Wellcome [WT108749/Z/15/Z].